Zhejiang Xinguang Pharmaceutical Co Ltd (300519) — Capital Reinvestment Ratio
Zhejiang Xinguang Pharmaceutical Co Ltd (300519) has a Capital Reinvestment Ratio of 0.02x as of March 2025, meaning it reinvests 0% of its operating cash flow (CN¥42.69 Million) in capital expenditures (CN¥839.89K). See 300519 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Xinguang Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Zhejiang Xinguang Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 14 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang Xinguang Pharmaceutical Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang Xinguang Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see Zhejiang Xinguang Pharmaceutical Co Ltd (300519) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥53.43 Million | CN¥5.20 Million | ▼ -67.6% |
| 2023 | 0.30x | CN¥53.29 Million | CN¥15.99 Million | ▲ +127.9% |
| 2022 | 0.13x | CN¥126.43 Million | CN¥16.64 Million | ▲ +27.4% |
| 2021 | 0.10x | CN¥142.36 Million | CN¥14.71 Million | ▲ +13.3% |
| 2020 | 0.09x | CN¥112.61 Million | CN¥10.27 Million | ▼ -44.0% |
| 2019 | 0.16x | CN¥98.27 Million | CN¥16.00 Million | ▼ -29.0% |
| 2018 | 0.23x | CN¥92.77 Million | CN¥21.27 Million | ▼ -6.3% |
| 2017 | 0.24x | CN¥124.23 Million | CN¥30.40 Million | ▲ +33.2% |
| 2016 | 0.18x | CN¥121.18 Million | CN¥22.27 Million | ▲ +54.6% |
| 2015 | 0.12x | CN¥124.84 Million | CN¥14.84 Million | ▼ -45.7% |
| 2014 | 0.22x | CN¥99.82 Million | CN¥21.85 Million | ▲ +74.3% |
| 2013 | 0.13x | CN¥57.51 Million | CN¥7.22 Million | ▲ +124.5% |
| 2012 | 0.06x | CN¥53.93 Million | CN¥3.02 Million | ▼ -67.0% |
| 2011 | 0.17x | CN¥34.40 Million | CN¥5.83 Million | — |